Literature DB >> 11306022

Activated caspase-3 expression in Alzheimer's and aged control brain: correlation with Alzheimer pathology.

J H Su1, M Zhao, A J Anderson, A Srinivasan, C W Cotman.   

Abstract

Several studies have suggested that activated caspase-3 has properties of a cell death executioner protease. In this study, we examined the expression of activated caspase-3 in AD and aged control brains. Activated caspase-3 immunoreactivity was seen in neurons, astrocytes, and blood vessels, was elevated in AD, and exhibited a high degree of colocalization with neurofibrillary tangles and senile plaques. These data suggest that activated caspase-3 may be a factor in functional decline and may have an important role in neuronal cell death and plaque formation in AD brain.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11306022     DOI: 10.1016/s0006-8993(01)02018-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  74 in total

Review 1.  Apoptotic mechanisms in Alzheimer neurofibrillary degeneration: cause or effect?

Authors:  Dennis W Dickson
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

2.  Caspase activation without apoptosis: insight into Aβ initiation of neurodegeneration.

Authors:  Bradley T Hyman
Journal:  Nat Neurosci       Date:  2011-01       Impact factor: 24.884

Review 3.  Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease.

Authors:  D Allan Butterfield; Miranda L Bader Lange; Rukhsana Sultana
Journal:  Biochim Biophys Acta       Date:  2010-02-20

4.  Calcium induces expression of cytoplasmic gelsolin in SH-SY5Y and HEK-293 cells.

Authors:  Lina Ji; Abha Chauhan; Ved Chauhan
Journal:  Neurochem Res       Date:  2010-03-26       Impact factor: 3.996

5.  Developmental shift in the apostat: comparison of neurones and astrocytes.

Authors:  Veronika Stoka; Sylvia F Chen; Vito Turk; Dale E Bredesen
Journal:  FEBS Lett       Date:  2005-10-11       Impact factor: 4.124

6.  Apolipoprotein E epsilon 4 is associated with an increased vulnerability to cell death in Alzheimer's disease.

Authors:  C Frey; A Bonert; T Kratzsch; G Rexroth; W Rösch; F Müller-Spahn; K Maurer; W E Müller; A Eckert
Journal:  J Neural Transm (Vienna)       Date:  2006-06-01       Impact factor: 3.575

7.  Caspases as therapeutic targets in Alzheimer's disease: is it time to "cut" to the chase?

Authors:  Troy T Rohn; Elizabeth Head
Journal:  Int J Clin Exp Pathol       Date:  2008-06-10

8.  Caspase-3 is enriched in postsynaptic densities and increased in Alzheimer's disease.

Authors:  Natalia Louneva; Julia W Cohen; Li-Ying Han; Konrad Talbot; Robert S Wilson; David A Bennett; John Q Trojanowski; Steven E Arnold
Journal:  Am J Pathol       Date:  2008-09-25       Impact factor: 4.307

9.  Age-related loss of phospholipid asymmetry in APP(NLh)/APP(NLh) x PS-1(P264L)/PS-1(P264L) human double mutant knock-in mice: relevance to Alzheimer disease.

Authors:  Miranda L Bader Lange; Daret St Clair; William R Markesbery; Christa M Studzinski; M Paul Murphy; D Allan Butterfield
Journal:  Neurobiol Dis       Date:  2010-01-18       Impact factor: 5.996

10.  Both the N-terminal fragment and the protein-protein interaction domain (PDZ domain) are required for the pro-apoptotic activity of presenilin-associated protein PSAP.

Authors:  Guozhang Mao; Jianxin Tan; Wei Gao; Yongchang Shi; Mei-Zhen Cui; Xuemin Xu
Journal:  Biochim Biophys Acta       Date:  2008-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.